Floatz logo

Berotralstat

Pediatric

BioCryst PharmaceuticalsSmall moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Pediatric cohort.

Asset / SponsorPhaseRating
VINBLASTINE
Memorial Sloan Kettering Cancer Center
Phase 2B
Procarbazine
Memorial Sloan Kettering Cancer Center
Phase 2B
Cyclophosphamide
Memorial Sloan Kettering Cancer Center
Phase 2B
PREDNISONE TABLETS
Memorial Sloan Kettering Cancer Center
Phase 2B
(+)-VINCRISTINE
Memorial Sloan Kettering Cancer Center
Phase 2B

View all 9 →

Same molecule, other indications

Berotralstat is also rated in:

hereditary angioedemaDormant
A
Indicative ·
82 / 100
View asset →
Advanced Solid Tumors With MTAP Gene DeletionDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →